News
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...
NDTV Profit on MSN2d
Bharat Biotech International's Cholera Vaccine Completes Phase III Clinical TrialsBharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback